| Product Code: ETC11389134 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
India`s anticoagulants import market saw significant growth with a CAGR of 29.1% from 2020 to 2024, although there was a slight decline in the growth rate from 2023 to 2024 at -5.85%. The top countries exporting anticoagulants to India in 2024 were the USA, Metropolitan France, China, India, and the UK, indicating a diverse range of sources. Despite the high concentration in the market, with the Herfindahl-Hirschman Index (HHI) remaining at elevated levels, the Indian anticoagulants import sector shows promising growth potential and continued interest from key global exporters.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Anticoagulants Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Anticoagulants Market Revenues & Volume, 2021 & 2031F |
3.3 India Anticoagulants Market - Industry Life Cycle |
3.4 India Anticoagulants Market - Porter's Five Forces |
3.5 India Anticoagulants Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 India Anticoagulants Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 India Anticoagulants Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 India Anticoagulants Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases and thromboembolic disorders in India |
4.2.2 Growing awareness about the importance of anticoagulant therapy among healthcare professionals and patients |
4.2.3 Rising geriatric population in India leading to higher demand for anticoagulant medications |
4.3 Market Restraints |
4.3.1 Stringent regulatory approval processes for new anticoagulant drugs in India |
4.3.2 Limited access to healthcare facilities and medications in rural areas of India |
4.3.3 High cost associated with anticoagulant therapy impacting affordability for some patient populations |
5 India Anticoagulants Market Trends |
6 India Anticoagulants Market, By Types |
6.1 India Anticoagulants Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 India Anticoagulants Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 India Anticoagulants Market Revenues & Volume, By Direct Oral Anticoagulants, 2021 - 2031F |
6.1.4 India Anticoagulants Market Revenues & Volume, By Vitamin K Antagonists, 2021 - 2031F |
6.1.5 India Anticoagulants Market Revenues & Volume, By Heparin, 2021 - 2031F |
6.2 India Anticoagulants Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 India Anticoagulants Market Revenues & Volume, By Oral, 2021 - 2031F |
6.2.3 India Anticoagulants Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3 India Anticoagulants Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 India Anticoagulants Market Revenues & Volume, By Deep Vein Thrombosis, 2021 - 2031F |
6.3.3 India Anticoagulants Market Revenues & Volume, By Atrial Fibrillation, 2021 - 2031F |
6.3.4 India Anticoagulants Market Revenues & Volume, By Pulmonary Embolism, 2021 - 2031F |
7 India Anticoagulants Market Import-Export Trade Statistics |
7.1 India Anticoagulants Market Export to Major Countries |
7.2 India Anticoagulants Market Imports from Major Countries |
8 India Anticoagulants Market Key Performance Indicators |
8.1 Rate of adoption of newer generation anticoagulant drugs in India |
8.2 Number of anticoagulant therapy clinics or centers established in key cities |
8.3 Patient adherence rates to prescribed anticoagulant therapy |
8.4 Number of research studies or clinical trials conducted on anticoagulant drugs in India |
8.5 Percentage of healthcare professionals trained in anticoagulant therapy management |
9 India Anticoagulants Market - Opportunity Assessment |
9.1 India Anticoagulants Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 India Anticoagulants Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 India Anticoagulants Market Opportunity Assessment, By Application, 2021 & 2031F |
10 India Anticoagulants Market - Competitive Landscape |
10.1 India Anticoagulants Market Revenue Share, By Companies, 2024 |
10.2 India Anticoagulants Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here